SCARB1 and cancer: In terms of targeting cancer ́s ability for extracellular cholesterol uptake, inhibiting cholesterol receptors LDLR and SR-B1 may not be enough, since cholesterol can also be taken up by cancer cells via macropinocytosis [7].